Grail (NASDAQ:GRAL – Get Free Report) had its price target upped by analysts at Morgan Stanley from $16.00 to $20.00 in a research note issued on Tuesday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s price target would suggest a potential downside of 26.09% from the stock’s previous close.
Grail Stock Performance
NASDAQ GRAL traded down $2.07 during trading hours on Tuesday, hitting $27.06. 367,313 shares of the company’s stock traded hands, compared to its average volume of 1,220,990. The business’s fifty day moving average price is $32.00 and its two-hundred day moving average price is $21.49. Grail has a 52 week low of $12.33 and a 52 week high of $63.99.
Grail (NASDAQ:GRAL – Get Free Report) last announced its earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.41) by $2.55. The business had revenue of $38.25 million for the quarter, compared to the consensus estimate of $35.33 million. On average, research analysts anticipate that Grail will post -15.15 earnings per share for the current year.
Insiders Place Their Bets
Hedge Funds Weigh In On Grail
A number of hedge funds have recently modified their holdings of GRAL. FNY Investment Advisers LLC bought a new position in shares of Grail during the fourth quarter worth $26,000. Lindbrook Capital LLC purchased a new stake in Grail during the fourth quarter valued at $28,000. State of Tennessee Department of Treasury purchased a new stake in Grail during the fourth quarter valued at $28,000. Sterling Capital Management LLC purchased a new stake in Grail during the fourth quarter valued at $29,000. Finally, Wellington Shields Capital Management LLC purchased a new stake in shares of Grail in the fourth quarter valued at $33,000.
About Grail
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Recommended Stories
- Five stocks we like better than Grail
- NYSE Stocks Give Investors a Variety of Quality Options
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- What is a Bond Market Holiday? How to Invest and Trade
- 3 Must-Own Stocks to Build Wealth This Decade
- Compound Interest and Why It Matters When Investing
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Grail Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grail and related companies with MarketBeat.com's FREE daily email newsletter.